A data-driven repricing solution that optimizes cost management and complements existing bill review workflows FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) — CorVel Corporation (Nasdaq: CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs. As medical billing continues to vary widely across states, providers, and care settings, traditional network and re-pricing approaches do not always reflect market pricing. Marketwise Repricing addresses this by integrating market-based reimbursement methods within CorVel’s existing bill review workflow. This approach captures additional savings that traditional bill review methods...

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter of 2026 ~ LEXINGTON, Mass. and AMSTERDAM, June 17, 2026 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that, during a recent Type B meeting with the U.S. Food and Drug Administration (FDA), the FDA communicated that the 3-year analysis from the Phase I/II study would be acceptable as the primary basis of a Biologics License Application (BLA) for the accelerated approval of AMT-130 in Huntington’s disease. In addition, the FDA seeks to align on the confirmatory study design prior to the BLA submission, including...

New iced signature drinks designed for oat drink lovers – made to enjoy at homeOatly x NespressoOatly and Nespresso return to bring iced coffee experience homeOatly x Nespresso Chilled Tropical EspressoNew iced signature drinks designed for oat drink lovers -made to enjoy at homeOatly x Nespresso Pink Dragon MochaNew iced signature drinks designed for oat drink lovers -made to enjoy at homeOatly x Nespresso Dirty Berry MatchaNew iced signature drinks designed for oat drink lovers -made to enjoy at homeOatly x Nespresso Mangoat Coconut LatteNew iced signature drinks designed for oat drink lovers -made to enjoy at homeMALMÖ, Sweden, June 17, 2026 (GLOBE NEWSWIRE) — Oatly Group AB (publ) (Nasdaq: OTLY) (“Oatly” or the “Company”), the world’s original and largest oat drink brand,...

CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the second quarter of 2026. The regular quarterly dividend, which equates to an annualized rate of $1.88 per common share, is payable on July 15, 2026, to shareholders of record as of the close of business on June 30, 2026. About Chicago Atlantic Real Estate Finance, Inc. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) is a market-leading commercial mortgage REIT utilizing significant real estate, credit and cannabis expertise to originate senior secured loans primarily to state-licensed cannabis operators in limited-license states in the United States. REFI is...

TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) — Sernova Biotherapeutics Inc. (“Sernova” or the “Company”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes, today announced that the U.S. Food and Drug Administration (“FDA”) has granted orphan drug designation for autologous islet transplantation (“AIT”) for the prevention of diabetes due to total pancreatectomy. Sernova’s proprietary Cell Pouch Bio-hybrid Organ is designed to support the engraftment and long-term function of transplanted therapeutic cells. Chronic Pancreatitis causes debilitating pain and can lead to a total pancreatectomy, resulting in the patient developing type 3c diabetes (T3cD) that is treated in the same way as type 1 diabetes...

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Starcore International Mines Ltd. (“Starcore”) (TSX: SAM; OTCQX: SHVLF), a growth-oriented mining company, has qualified to trade on the OTCQX® Best Market. Starcore upgraded to OTCQX from the Pink Limited™ Market. Starcore begins trading today on OTCQX under the symbol “SHVLF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home...

ROUYN-NORANDA, Quebec, June 17, 2026 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (TSX-V: ABI) (OTCQB: ABMBF) continues its work toward commercial production. The current 40,632 meters of this drilling campaign contributes to strengthening its assets and confirming the potential of the Sleeping Giant mine, its main project. Highlights for Investors:Intensification of the drilling rate: 40,632 m completed in 370 holes since December 2023, including 15,371 m completed in 2026.Operational acceleration: Deployment of a third drill to reach a rate of 4,500 m per month.High-grade results: Notable intersections including 170.9 g/t Au over 0.8 m and 107.7 g/t Au over 0.5 m.Future progress: Definition work strengthens the mining plan and optimizes operations for 2027.Drilling Strategy: Convert to Produce Abcourt goes beyond drilling...

Technology to debut at Innofibre’s newly launched research & pilot stage facility MONTREAL, June 17, 2026 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today a collaborative project to convert contaminated biomass into syngas with its client Innofibre – Centre d’innovation des produits cellulosiques, a CCTT (“College Centre for the Transfer of Technologies”) at the Cégep de Trois-Rivières. The CCTT is focused on the paper and biorefining industry in Quebec. PyroGenesis’ technology was included during the launch of Innofibre’s new $14 million pilot and pre-commercial facility. The centre is the only one of its...

With both FEED programs now awarded, Brazil Potash has secured comprehensive engineering design coverage across the entire Autazes Project, a key requirement for construction debt financing discussions currently underway with Development Finance Institutions (DFIs) and Export Credit Agencies (ECAs)Redpath Mining Inc., with 500+ shafts completed globally including among the most complex potash shafts of the last decade, engaged as subconsultants under the FEED for mine shafts and underground development, the critical path that defines the entire Autazes Project construction scheduleFollowing the award of the Surface Facilities and Infrastructure FEED to Wood and Promon Engenharia, this award completes full engineering design coverage across the entire Autazes ProjectMANAUS, Brazil, June 17, 2026 (GLOBE NEWSWIRE) — Brazil...

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces that, further to its news release dated May 20, 2026, the Company has closed its non-brokered private placement for gross proceeds of $1,254,000 by issuing 25,080,000 Units at $0.05 per Unit on June 16, 2026. Rodger Seccombe, CEO of Avricore stated, “This financing provides the Company with the capital strength for its UK expansion. We appreciate the commitment from our investors as we prepare to execute on our growth strategy.” Each Unit consists of one common share and one-half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 2 years from the closing date of the offering at a price of $0.10 per...